Summary Judgment in Favor of Edwards Lifesciences

Morris Nichols successfully defended longtime client Edwards Lifesciences in a patent-infringement suit brought by Aortic Innovations over Edwards’ SAPIEN 3 Ultra transcatheter aortic valve replacement product. On March 12, 2026, just days before a trial was scheduled, the US District Court for the District of Delaware granted a motion for summary judgment in favor of Edwards, finding all four patents-in-suit invalid.

Morris Nichols’ IP litigation team of Brian Egan and Anthony Raucci worked alongside attorneys from Knobbe Martens and Goldman Ismail Tomaselli Brennan & Baum to achieve this significant outcome for Edwards.